NCT06804837 · ACTIVE NOT RECRUITING
Implement and Test Visual Consent Template and Process
This trial is testing whether a visual, easier-to-read consent form helps patients better understand what they are agreeing to before joining a research study. It is not testing a drug or medical treatment — it is studying the consent process itself. Researchers will compare a visual consent template against the standard paperwork. This is a Phase NA administrative and process study, meaning it is focused on research design, not medical outcomes.
Eligibility criteria
Eligibility Criteria for Patients:
* Adult participants (18+) eligible for one of three participating trials at Washington University, University of Utah, or University of North Carolina at Chapel Hill. The eligibility criteria for the main trials are below:
* UNC:
* Basal-like PDAC Treated with Gemcitabine, Erlotinib, and Nab-paclitaxel (PANGEA) trial inclusion criteria:
* Written informed consent was obtained to participate in the study and HIPAA authorization for release of personal health information.
* Participant is willing and able to comply with study procedures based on the judgment of the investigator.
* Age ≥ 18 years at the time of consent.
* Eastern Cooperative Oncology Group (ECOG) Performance Status of 0-1.
* Consent to a mandatory pre-study biopsy if archival tissue is not available or sufficient.
* Participants with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen.
* Washington University:
* Returning Research Results That Indicate Risk of Alzheimer Disease Dementia to Healthy Participants in Longitudinal Studies (WeSHARE)
* Participants of the Knight Alzheimer Disease Research Center.
* Participants with available results from an Alzheimer Disease blood biomarker test.
* Participants who agreed to be contacted for additional research studies.
* University of Utah:
* Huntsman Cancer Institute Total Cancer Care
* Participants who have been diagnosed with any type of tumor or cancer.
* Participants with genetic predispositions or family history of cancer or tumors.
* Participant volunteers willing to share samples and data for research.
Eligibility Criteria for Research Staff:
* Research staff/coordinators of one of the three participating trials at Washington University, University of Utah, or University of North Carolina at Chapel Hill.The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-04-27